Site Search | NIAMS

Displaying 701 - 720 of 1039 results

La historia de Ana

https://www.niams.nih.gov/health-topics/sports-injuries/anas-story

Fecha de publicación marzo de 2012 descargue la versión PDF en inglés (4.7 MB) descargue la versión en PDF en español (4.6 MB) Ésta es una historia sobre una niña llamada Ana y cómo ella y su familia aprendieron acerca de las lesiones deportivas y cómo tratarlas. La portada muestra

Infografía: ¿Por qué los investigadores realizan distintos tipos de estudios clínicos?

https://www.niams.nih.gov/infografia-por-que-los-investigadores-realizan-distintos-tipos-de-estudios-clinicos

En la parte derecha superior hay una imagen de tres científicos. Uno de ellos está escribiendo sobre un pizarrón. Otro está revisando documentos sobre la mesa. Una científica está escribiendo en su computadora portátil. Esta infografía explica que la investigación clínica es el estudio de la salud y las enfermedades

Amy Coxon, Ph.D.

https://www.niams.nih.gov/about/directory/amy-coxon-phd

Dr. Amy Coxon applies her expertise in molecular biology, mouse genetics, and xenograft models to investigate the pathobiology of merkel cell carcinoma (MCC) with the goal of identifying novel therapeutic targets.

Natasha T. Hill, Ph.D.

https://www.niams.nih.gov/about/directory/natasha-t-hill-phd

Dr. Hill’s current research uses genomic and proteomic techniques to investigate the pathobiology of Merkel cell carcinoma (MCC), a neuroendocrine skin cancer that predominantly occurs in elderly and immunosuppressed populations.

PROMIS

https://www.niams.nih.gov/promis

New paradigms for how clinical research information is collected, used and reported.

All NIAMS News

https://www.niams.nih.gov/newsroom/all-news

A list of all NIAMS related news articles, stories, blog posts, and announcements.

Press Releases

https://www.niams.nih.gov/newsroom/press-releases

Labs Grouped by Research Area

https://www.niams.nih.gov/labs/research-areas

The research conducted by NIAMS investigators and clinicians spans many fields of science. We invite you to explore our laboratories, which are grouped according to several major scientific focus areas.

History of Actual Obligations (1987 to 2019)

https://www.niams.nih.gov/about/budget/past-budgets/history-actual-obligations

The NIAMS provides budget information for research and training grants.

History of Competing Research Project Grants (RPG)

https://www.niams.nih.gov/about/budget/past-budgets/history-competing-project-grants

The NIAMS provides budget information for research and training grants from 2006 to date.

Meetings & Events

https://www.niams.nih.gov/newsroom/meetings-events

Resource-based Centers (P30) FAQs

https://www.niams.nih.gov/grants-funding/funding-opportunities/activity-codes/faqs-resource-centers

Read common questions about NIAMS Resource-based Centers that provide research infrastructure, shared facilities, services, and resources to researchers.

NIAMS-funded clinical trials actively recruiting.

Administrative Management Branch - AMB-OD

https://www.niams.nih.gov/about/organization/office-director/administrative-management-branch-amb-od

This page is a staff listing page of the people in the Administrative Management Branch - AMB-OD

Administrative Management Branch - AMB-IRP

https://www.niams.nih.gov/about/organization/intramural-research-program/administrative-management-branch

The IRP Administrative Management Branch performs a full range of general administrative and advisory services and functions:

Herman Utama

https://www.niams.nih.gov/about/directory/herman-utama

Herma Utama, Financial Management Branch - FMB

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

https://www.niams.nih.gov/grants-funding/niams-current-funding-opportunities/late-stage-translation-biomedical-and-behavioral

This funding opportunity ( PAR-23-032) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that translate technology and therapeutic innovations from academic and other non-profit research sectors to the marketplace to advance the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic or skin